Spread the love

Definition: When did the first clinical trials using CRISPR technology begin?

The first clinical trials using CRISPR technology began in 2016. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing tool that allows scientists to make precise changes to the DNA of living organisms. It has the potential to treat a wide range of genetic diseases by correcting or modifying faulty genes.

The first clinical trial using CRISPR technology was conducted by a team of researchers at Sichuan University in China. They aimed to use CRISPR to modify immune cells in patients with advanced lung cancer, with the goal of enhancing the immune system’s ability to fight the disease. The trial involved removing immune cells from the patients, editing them using CRISPR to disable a gene that inhibits the immune response, and then reintroducing the modified cells back into the patients’ bodies.

See also How does telomere extension technology differ from other anti-aging treatments?

Since then, several other clinical trials using CRISPR technology have been initiated around the world. These trials are exploring the potential of CRISPR for treating various diseases, including cancer, blood disorders, and genetic disorders. While the field of CRISPR-based therapies is still in its early stages, these clinical trials represent an important step towards harnessing the power of gene editing to improve human health.

Keywords: crispr, clinical, trials, technology, immune, editing, patients, potential, genetic